To study the impact of myocardial delivery of PSAT1 modRNA on cardiac remodeling and function post-MI, we analyzed cardiac function and structure 28 days after PSAT1 modRNA delivery (Figure 3A). This evidence concerns the gene PSAT1 and myocardial infarction.